162 related articles for article (PubMed ID: 17436850)
61. [Pancreas and islets of Langerhans transplantation: current status in 2009 and perspectives].
Niclauss N; Morel P; Volonte F; Bosco D; Berney T
Rev Med Suisse; 2009 Jun; 5(206):1266-70, 1272. PubMed ID: 19579422
[TBL] [Abstract][Full Text] [Related]
62. Successful islet transplantation to two recipients from a single donor by targeting proinflammatory cytokines in mice.
Satoh M; Yasunami Y; Matsuoka N; Nakano M; Itoh T; Nitta T; Anzai K; Ono J; Taniguchi M; Ikeda S
Transplantation; 2007 Apr; 83(8):1085-92. PubMed ID: 17452899
[TBL] [Abstract][Full Text] [Related]
63. Experience of microbiological screening of human hepatocytes for clinical transplantation.
Lehec SC; Hughes RD; Mitry RR; Graver MA; Verma A; Wade JJ; Dhawan A
Cell Transplant; 2009; 18(8):941-7. PubMed ID: 19523347
[TBL] [Abstract][Full Text] [Related]
64. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.
Goss JA; Goodpastor SE; Brunicardi FC; Barth MH; Soltes GD; Garber AJ; Hamilton DJ; Alejandro R; Ricordi C
Transplantation; 2004 Feb; 77(3):462-6. PubMed ID: 14966428
[TBL] [Abstract][Full Text] [Related]
65. "Real-time" assessment of human islet preparations with confocal live cell imaging.
Hermann M; Pirkebner D; Draxl A; Margreiter R; Hengster P
Transplant Proc; 2005 Oct; 37(8):3409-11. PubMed ID: 16298610
[TBL] [Abstract][Full Text] [Related]
66. Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.
Qi M; Omori K; Mullen Y; McFadden B; Valiente L; Juan J; Bilbao S; Tegtmeier BR; Dafoe D; Kandeel F; Al-Abdullah IH
Transplant Direct; 2016 Feb; 2(2):e63. PubMed ID: 26894230
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of engraftment after single islet transplantation from a brain-dead donor by the secretory unit of islet transplant objects (SUITO) index.
Matsumoto S; Noguchi H; Hatanaka N; Kobayashi N; Jackson A; Naziruddin B; Levy M-
Transplant Proc; 2008 Mar; 40(2):364-6. PubMed ID: 18374069
[TBL] [Abstract][Full Text] [Related]
68. Autotransplantation of culture-positive islet product: is dirty always bad?
Johnson CN; Morgan KA; Owczarski SM; Wang H; Fried J; Adams DB
HPB (Oxford); 2014 Jul; 16(7):665-9. PubMed ID: 24308511
[TBL] [Abstract][Full Text] [Related]
69. Validation of the scoring system for standardization of the pancreatic donor for islet isolation as used in a new islet isolation center.
Witkowski P; Liu Z; Cernea S; Guo Q; Poumian-Ruiz E; Herold K; Hardy MA
Transplant Proc; 2006 Nov; 38(9):3039-40. PubMed ID: 17112894
[TBL] [Abstract][Full Text] [Related]
70. Testing combinations of protease inhibitor and preservation solution to improve islet quality and yield.
Al-Abdullah IH; Bentsi-Barnes K; Valiente L; Omori K; Iglesias I; Orr C; Umeadi C; Ferreri K; Todorov I; Al-Sayed M; Kandeel F
Transplant Proc; 2008 Mar; 40(2):390-2. PubMed ID: 18374078
[TBL] [Abstract][Full Text] [Related]
71. Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation.
Ferrari-Lacraz S; Berney T; Morel P; Marangon N; Hadaya K; Demuylder-Mischler S; Pongratz G; Pernin N; Villard J
Transplantation; 2008 Jul; 86(2):357-9. PubMed ID: 18645502
[TBL] [Abstract][Full Text] [Related]
72. A new preservation solution increases islet yield and reduces graft immunogenicity in pancreatic islet transplantation.
Giraud S; Claire B; Eugene M; Debre P; Richard F; Barrou B
Transplantation; 2007 May; 83(10):1397-400. PubMed ID: 17519794
[TBL] [Abstract][Full Text] [Related]
73. Necessities for a Clinical Islet Program.
Hawthorne WJ
Adv Exp Med Biol; 2016; 938():67-88. PubMed ID: 27586423
[TBL] [Abstract][Full Text] [Related]
74. Comparison of the collagen VI content within the islet-exocrine interface of the head, body, and tail regions of the human pancreas.
Hughes SJ; McShane P; Contractor HH; Gray DW; Clark A; Johnson PR
Transplant Proc; 2005 Oct; 37(8):3444-5. PubMed ID: 16298623
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of the sterility test for detection of microbial contaminants of allografts.
Alexander K; Bryans T
Cell Tissue Bank; 2006; 7(1):23-8. PubMed ID: 16511661
[TBL] [Abstract][Full Text] [Related]
76. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact.
Lowder JN; Whelton P
Cytotherapy; 2003; 5(5):377-90. PubMed ID: 14578100
[TBL] [Abstract][Full Text] [Related]
77. Bacterial contamination of organ graft preservation solution and infection after transplantation.
Sauget M; Verdy S; Slekovec C; Bertrand X; Talon D
Transpl Infect Dis; 2011 Aug; 13(4):331-4. PubMed ID: 21281417
[TBL] [Abstract][Full Text] [Related]
78. Clinical significance of bacterial cultures from 28 autologous islet cell transplant solutions.
Wray CJ; Ahmad SA; Lowy AM; D'Alessio DA; Gelrud A; Choe KA; Soldano DA; Matthews JB; Rodriguez-Rilo HL
Pancreatology; 2005; 5(6):562-9. PubMed ID: 16110254
[TBL] [Abstract][Full Text] [Related]
79. The effect of truncated collagenase class I isomers on human islet isolation outcome.
Brandhorst H; Asif S; Andersson K; Mönch J; Friedrich O; Rämsch-Günther N; Rämsch C; Steffens M; Lambrecht J; Schräder T; Kurfürst M; Andersson HH; Felldin M; Foss A; Salmela K; Tibell A; Tufveson G; Korsgren O; Brandhorst D
Transplantation; 2010 Aug; 90(3):334-5. PubMed ID: 20683429
[No Abstract] [Full Text] [Related]
80. Cost analysis of human islet transplantation for the treatment of type 1 diabetes in the Swiss-French Consortium GRAGIL.
Guignard AP; Oberholzer J; Benhamou PY; Touzet S; Bucher P; Penfornis A; Bayle F; Kessler L; Thivolet C; Badet L; Morel P; Colin C;
Diabetes Care; 2004 Apr; 27(4):895-900. PubMed ID: 15047645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
